EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome

Sneha Shah, Daniel Barnes, Botao Liu, Tenzin Tseyang, Thang Do, Jodi L Bubenik, Suna Jung, Mina N Anadolu, Maria P Ivshina, Verónica Martínez-Cerdeño, Elizabeth Berry-Kravis, Maurice S Swanson und 2 weitere

Cell Reports · 2026-01 · 45 (1) · 116857

DOI: 10.1016/j.celrep.2025.116857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Sneha Shah und 13 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: sneha.shah@umassmed.edu. Hauptthemen laut MEDLINE: Glutaminase, Fragile X Syndrome, Neurons, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic homeostasis gone awry is a contributor to, if not an underlying cause of, several neurologic disorders. Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a trinucleotide repeat expansion in FMR1 and consequent loss of the encoded protein FMRP, which results in downstream molecular, neurologic, and mitochondrial deficits that are linked to cognitive impairment. In the human postmortem brain, many metabolites and solute carrier proteins are coordinately dysregulated, which also occurs during the differentiation of human induced pluripotent stem cells (iPSCs) into excitatory neurons. Metabolic tracing in FXS neurons demonstrates a dearth of glutamine deamidation to glutamate, which reduces anaplerosis into the TCA cycle, potentially hindering the bioenergetic and biosynthetic functions of mitochondria. Mechanistically, aberrant expression of glutaminase isoforms in FXS is responsible for reduced glutaminolysis, thereby altering glutamate levels, which may contribute to FXS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutaminaseFragile X SyndromeNeuronsCell DifferentiationHumansInduced Pluripotent Stem CellsMetabolic ReprogrammingGlutamic AcidGlutamineMitochondria

Stichwörter der Autor:innen

CP: metabolismCP: neuroscienceFragile X syndromeglutamate transportersglutaminasehuman neuronsiPSCmetabolomics

Substanzen

GlutaminaseGlutamic AcidGlutamine

Autor:innen und Institutionen

  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: sneha.shah@umassmed.edu.
  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
  • Department of Molecular Genetics and Microbiology, Center for NeuroGenetics and the Genetics Institute, University of Florida, College of Medicine, Gainesville, FL 32610-3610, USA.
  • Department of Pathology and Laboratory Medicine, Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children of Northern California, Sacramento, CA, USA; MIND Institute at the UC Davis Medical Center,…
  • Departments of Pediatrics, Neurological Sciences, Anatomy and Cell Biology, RUSH Pediatric Neurosciences F.A.S.T., Center for Translational Research, Rush University Medical Center, Chicago, IL 60612, USA.
  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: joel.richter@umassmed.edu.

Förderung

  • NIMH NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • Harvard Medical School
  • FRAXA Research Foundation
  • National Institute of General Medical Sciences
  • National Institute of Neurological Disorders and Stroke
  • Center for Clinical and Translational Science, University of Massachusetts

Zitieren

APA

Shah, S., Barnes, D., Liu, B., Tseyang, T., Do, T., Bubenik, J. L., Jung, S., Anadolu, M. N., Ivshina, M. P., Martínez-Cerdeño, V., Berry-Kravis, E., Swanson, M. S., Spinelli, J. B., & Richter, J. D. (2026). Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome. Cell Reports, 45(1), 116857. https://doi.org/10.1016/j.celrep.2025.116857

Vancouver

Shah S, Barnes D, Liu B, Tseyang T, Do T, Bubenik JL, et al. Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome. Cell Reports. 2026;45(1):116857. doi:10.1016/j.celrep.2025.116857

BibTeX
@article{Shah2026,
  author = {Shah, Sneha and Barnes, Daniel and Liu, Botao and Tseyang, Tenzin and Do, Thang and Bubenik, Jodi L and Jung, Suna and Anadolu, Mina N and Ivshina, Maria P and Martínez-Cerdeño, Verónica and Berry-Kravis, Elizabeth and Swanson, Maurice S and Spinelli, Jessica B and Richter, Joel D},
  title = {Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {1},
  pages = {116857},
  doi = {10.1016/j.celrep.2025.116857}
}
Kostenlos starten →